Matching articles for "lopinavir/ritonavir"

Remdesivir (Veklury) for COVID-19

   
The Medical Letter on Drugs and Therapeutics • November 30, 2020;  (Issue 1612)
The FDA has approved the antiviral drug remdesivir (Veklury – Gilead) for IV treatment of COVID-19 in hospitalized patients who are ≥12 years old and weigh ≥40 kg. Hospitalized children who are...
The FDA has approved the antiviral drug remdesivir (Veklury – Gilead) for IV treatment of COVID-19 in hospitalized patients who are ≥12 years old and weigh ≥40 kg. Hospitalized children who are <12 years old or weigh <40 kg can receive remdesivir through an Emergency Use Authorization (EUA). Remdesivir is the first drug to be approved in the US for treatment of COVID-19.
Med Lett Drugs Ther. 2020 Nov 30;62(1612):186-8 | Show Full IntroductionHide Full Introduction